Trending Now
Reason why IBRX could reward early traders and investors
ImmunityBio, Inc. (NASDAQ: IBRX) recently made waves in the medical community with its pioneering immunotherapy, ANKTIVA® (nogapendekin alfa inbakicept-pmln), marking a significant...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Ambrx Biopharma Inc ($AMAM) rally could continue as biotech sector heats...
Ambrx Biopharma Inc (NYSE: AMAM) stock surged more than 1000% on Friday after the biotech company announced preliminary safety and efficacy data from...
MAKE IT MODERN
LATEST REVIEWS
The Big Picture for Virus Testing Stocks (FLGT, ALST, CODX)
The good news is that the end of the pandemic is in sight. The bad news is that it may never really...
MAKE IT MODERN
PERFORMANCE TRAINING
Silvergate Capital Corp (NYSE:SI) Dramatic Surge: Exploring Potential Causes and Future Prospects Amid Industry...
Silvergate Capital Corp (NYSE: SI) experienced a significant increase of 52.21%, with its value rising from 1.7200 to 2.3100. The stock's prior...
What to expect from Johnson & Johnson (JNJ) earnings
Johnson & Johnson (NYSE:JNJ) last traded at $168.74. The stock is up over 3% over the course of the year.
Axovant Gene Therapies Ltd (NASDAQ:AXGT) Receives Rare Pediatric Disease Designation For Its One-Time Gene...
Axovant Gene Therapies Ltd (NASDAQ:AXGT) recently announced that it was awarded rare disease designation for AXO-AAV-GM2, a gene therapy that it has been developing...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Genmab (NASDAQ: GMAB) Reports 1H 2021 Revenue of DKK 2.55 Billion Driven by DARZALEX...
Genmab (NASDAQ: GMAB) has announced financial results for 1H 2021 and provided corporate updates.
1H 2021 DARZALEX revenue up 52%
In the first half of 2021,...
MAKE IT MODERN
